Get started
Work

Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol

Year: 2024
Type: article
Study design: Case Report
Abstract: Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.
Source: Infection
DOI: 10.1007/s15010-024-02404-9
Authors: Janina Trauth, Rahel Schuler, Markus Waitz, Harald Ehrhardt, Moritz Fritzenwanker, Susanne Herold
Institutions: Justus-Liebig-Universität Gießen, German Center for Infection Research, German Center for Lung Research, Cardio-Pulmonary Institute, Universität Ulm, University Hospital Ulm
Language: English
Subfield: Endocrinology
Open Access status: hybrid
Estimated APC paid: $4,590
OpenAlex ID: W4403189776
FWCI: 1.072
Cites: 22
Cited by: 4
Related to: 10